Histiocytic disorders
KL McClain, C Bigenwald, M Collin… - Nature Reviews …, 2021 - nature.com
The historic term 'histiocytosis' meaning 'tissue cell'is used as a unifying concept for
diseases characterized by pathogenic myeloid cells that share histological features with …
diseases characterized by pathogenic myeloid cells that share histological features with …
Langerhans cell histiocytosis
C Rodriguez-Galindo, CE Allen - Blood, The Journal of the …, 2020 - ashpublications.org
Langerhans cell histiocytosis (LCH) is caused by clonal expansion of myeloid precursors
that differentiate into CD1a+/CD207+ cells in lesions that leads to a spectrum of organ …
that differentiate into CD1a+/CD207+ cells in lesions that leads to a spectrum of organ …
Langerhans-cell histiocytosis
Langerhans-Cell Histiocytosis A spectrum of diseases formerly known as histiocytosis X and
now called Langerhans-cell histiocytosis is characterized by ERK pathway activation …
now called Langerhans-cell histiocytosis is characterized by ERK pathway activation …
How I treat Langerhans cell histiocytosis
CE Allen, S Ladisch, KL McClain - Blood, The Journal of the …, 2015 - ashpublications.org
Abstract “Langerhans cell histiocytosis”(LCH) describes a spectrum of clinical presentations
ranging from a single bone lesion or trivial skin rash to an explosive disseminated disease …
ranging from a single bone lesion or trivial skin rash to an explosive disseminated disease …
Progress in understanding the pathogenesis of Langerhans cell histiocytosis: back to Histiocytosis X?
Langerhans cell histiocytosis (LCH), the most common histiocytic disorder, is characterized
by the accumulation of CD 1A+/CD 207+ mononuclear phagocytes within granulomatous …
by the accumulation of CD 1A+/CD 207+ mononuclear phagocytes within granulomatous …
Histiocytic neoplasms, version 2.2021, NCCN clinical practice guidelines in oncology
RS Go, E Jacobsen, R Baiocchi, I Buhtoiarov… - Journal of the National …, 2021 - jnccn.org
Histiocytic neoplasms are rare hematologic disorders accounting for less than 1% of cancers
of the soft tissue and lymph nodes. Clinical presentation and prognosis of these disorders …
of the soft tissue and lymph nodes. Clinical presentation and prognosis of these disorders …
Langerhans cell histiocytosis in children–a disease with many faces. Recent advances in pathogenesis, diagnostic examinations and treatment
M Jezierska, J Stefanowicz, G Romanowicz… - … in Dermatology and …, 2018 - termedia.pl
Langerhans cell histiocytosis is a rare clonal disease characterized by the proliferation of
CD1a-positive immature dendritic cells. The purpose of this article was to present an …
CD1a-positive immature dendritic cells. The purpose of this article was to present an …
Pediatric lymphomas and histiocytic disorders of childhood
Lymphomas are the third most common malignancy among children and adolescents. 1, 2 In
children less than 15 years of age, non-Hodgkin Lymphoma (NHL) is more frequent; …
children less than 15 years of age, non-Hodgkin Lymphoma (NHL) is more frequent; …
Diverse cutaneous presentations of Langerhans cell histiocytosis in children: a retrospective cohort study
MA Morren, K Vanden Broecke… - Pediatric blood & …, 2016 - Wiley Online Library
Background Langerhans cell histiocytosis (LCH) is a rare disease, frequently affecting
young children. Procedure We performed a retrospective study in patients younger than 16 …
young children. Procedure We performed a retrospective study in patients younger than 16 …
Langerhans cell histiocytosis: A neoplastic disorder driven by Ras-ERK pathway mutations
G Tran, TN Huynh, AS Paller - Journal of the American Academy of …, 2018 - Elsevier
Langerhans cell histiocytosis (LCH) is a disorder of myeloid neoplasia of dendritic cells that
affects 1 in 200,000 children< 15 years of age and even fewer adults. LCH presents with a …
affects 1 in 200,000 children< 15 years of age and even fewer adults. LCH presents with a …